by The acute repetitive seizures market consists of medications that are used for the treatment of acute repetitive seizures. These medications work by altering the levels of neurotransmitters in the brain like GABA and glutamate which helps in controlling excessive neuronal activity and seizure activity.
The global acute repetitive seizures market size is estimated to be valued at US$ 3.10 billion in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
Acute repetitive seizures refer to two or more unprovoked seizures occurring over a 24-hour period without recovery of consciousness between seizures. The medications used in the treatment include benzodiazepines, antiepileptic drugs and sedative hypnotics. These medications provide rapid relief from seizures and prevents further seizure episodes. The growing prevalence of epilepsy and increasing R&D investments by key players for development of advanced treatment options are fueling the growth of this market.
Key Takeaways
Acute Repetitive Seizures Companies operating in the acute repetitive seizures market are Neurelis, Inc., Bausch Health Companies Inc., Alexza Pharmaceuticals, Inc., VERITON PHARMA, UCB S.A., Takeda Pharmaceutical Company Limited, Pfizer Inc., Sanofi, GSK plc, Eisai Co., Ltd., H. Lundbeck A/S, Cognizance Biomarkers, LLC.
The growing incidence of epilepsy globally mainly due to increasing risk factors like family history of epilepsy, brain injury, stroke, central nervous system infections is driving the demand for acute repetitive seizures treatment. According to World Health Organization, around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally.
The key market players are expanding their presence globally with focus on emerging markets of Asia Pacific and Latin America. Fragmented regulations, increasing healthcare expenditure, and growing medical tourism are factoring the global expansion of acute repetitive seizures market.
Market Key Trends
The rapidly improving healthcare infrastructure and increasing personal disposable income in developing regions is boosting the demand for advanced acute repetitive seizures treatment medications. The key players are focusing on development of novel drug delivery systems like intranasal sprays to provide rapid relief from seizures. Continuous efforts are underway for development of medications with minimal side effects and long duration of action. Collaboration between academia and pharmaceutical companies will further advance the acute repetitive seizures treatment landscape.
Porter’s Analysis
Threat of new entrants: The biopharmaceutical industry requires huge investments which acts as a barrier for new players. Bargaining power of buyers: Individual customers have low bargaining power due to lack of alternatives and need for seizure treatment.
Bargaining power of suppliers: Suppliers have moderate power due to technologies and formulation expertise required.
Threat of new substitutes :Potential substitutes are limited due to specificity of conditions treated. Competitive rivalry as High due to focus on innovation and patent cliff of blockbuster drugs.
Geographical Regions
North America region holds the major share currently due to developed healthcare infrastructure and supportive reimbursement policies. The United States accounts for the largest market owing to presence of advanced healthcare facilities and high treatment awareness levels.
Asia Pacific region is expected to witness the fastest growth during the forecast period due to rising healthcare expenditures, increasing disposable incomes, and growing focus on rare disease treatment in emerging economies like India and China. Rapidly evolving healthcare systems and expansion of medical insurance coverage will further drive the regional market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
